Results 291 to 300 of about 685,668 (343)

RNA editing deficiency models differential immunogenicity of pancreatic α- and β-cells. [PDF]

open access: yesMol Metab
Peleg S   +12 more
europepmc   +1 more source

Smooth muscle expression of RNA editing enzyme ADAR1 controls activation of RNA sensor MDA5 in atherosclerosis

open access: green
Chad S. Weldy   +21 more
openalex   +2 more sources

AAV delivery of RNA editing machinery rescues SUDEP and seizure phenotype in a mouse model of Dravet Syndrome

open access: yes
Chilcott EM   +10 more
europepmc   +1 more source

RNA editing is a molecular clock in unmodified human cells

open access: yes
Ghareeb AE   +14 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

RNA Editing

Annual Review of Neuroscience, 1996
RNA editing is a term describing a variety of novel mechanisms for the modification of nucleotide sequences of RNA transcripts in different organisms. These editing events include (a) the U-insertion and -deletion type of editing found in the mitochondrion of kinetoplastid protozoa, (b) the C-insertion editing found in the mitochondrion of Physarum ...
L, Simpson, R B, Emeson
openaire   +3 more sources

RNA editing

Molecular Biology, 2007
RNA editing is a collective term referring to a plethora of reactions that ultimately lead to changes in RNA nucleotide sequence apart from splicing, 5' capping or 3' end processing. Spread throughout the Eukarya, RNA editing creates genetic information de novo, alters decoding capacity, or influences structure and stability of RNA by inserting ...
  +6 more sources

Organellar RNA editing

WIREs RNA, 2011
AbstractRNA editing is a term used for a number of mechanistically different processes that alter the nucleotide sequence of RNA molecules to differ from the gene sequence. RNA editing occurs in a wide variety of organisms and is particularly frequent in organelle transcripts of eukaryotes.
Chateigner Boutin, Anne Laure   +1 more
openaire   +4 more sources

RNA Editing in Interferonopathies

2020
The type I interferonopathies comprise a heterogenous group of monogenic diseases associated with a constitutive activation of type I interferon signaling.The elucidation of the genetic causes of this group of diseases revealed an alteration of nucleic acid processing and signaling.ADAR1 is among the genes found mutated in patients with this type of ...
Frassinelli L.   +3 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy